Left to right: Barnaby Perks, CEO of Oxford VR, and Ash Patel, Optum Ventures principal; Credit: Oxford VR
February 12, 2020
British firm Oxford VR has secured £10 million in a Series A funding round led by Optum Ventures, with support from Luminous Ventures. Existing backers Oxford Sciences Innovation, Oxford University Innovation and GT Healthcare Capital Partners also participated.
WHAT THEY DO
Oxford VR, a spinout from the department of psychiatry at the University of Oxford, was founded in 2017. It builds on two...
June 17, 2019
Oxford VR, an Oxford University spinout company, has announced the launch of its leading-edge treatment for common mental health conditions through a unique partnership with AXA HK and the Chinese University of Hong Kong (CUHK).
Dubbed ‘Yes I Can’, the initiative will offer a ground-breaking treatment using virtual reality (VR) technology. It will be free to the public and to AXA’s corporate...
(Photo from left to right): Professor Fanny Cheung, Pro-Vice-Chancellor / Vice-President of CUHK, Gordon Watson, Chief Executive Officer of AXA Asia and Barnaby Perks, Chief Executive Officer of Oxford VR at the signing of Asia’s first partnership for mental wellbeing using immersive VR. Credit: AXA Hong Kong
April 30, 2019
AXA Hong Kong, The Chinese University of Hong Kong (CUHK) and Oxford VR (OVR) announced a first-of-a-kind partnership to pilot a groundbreaking automated immersive therapy using virtual reality (VR) for mental health in Asia including the Greater Bay Area.
What’s it about
The pilot focuses on a jointly supported clinically-validated trial in Hong Kong using a modern VR technology platform for...
September 20, 2018
Looking to commercialize its virtual reality mental health treatment, Oxford VR has announced that it raked in $4.11 (£3.2 million) in funding. Investors included Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital, and GT Healthcare Capital Partners.
"Our focus is on developing clinically validated, cost-effective, user-centred treatments for clinical conditions with...